Clinical trials / NCT05506943
NCT05506943Phase 2, phase 3Active not recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Study sponsor: Compass Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2027-08-31Estimated
Enrollment · participants168Actual
Source updated2026-09-02Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

1 Dec 2026

+ After

31 Aug 2027

Check registry source

· 3 fields changed

Completion date type changed

− Before

Actual

+ After

Estimated

Primary completion date changed

− Before

21 Jan 2026

+ After

1 Dec 2026

Recruitment status changed

− Before

Completed

+ After

Active not recruiting

Check registry source

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

150 participants (planned)

+ After

168 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Jul 2025

+ After

21 Jan 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source